Bioluminescence imaging visualizes activation of nuclear factor-κB in mouse cardiac transplantation

Transplantation

Volumn 85, Issue 6, 2008, Pages 903-910

  Ma, Lianli ^a   Xiang, Zhidan ^a   Sherrill, Taylor P ^a   Wang, Lei ^a   Blackwell, Timothy S ^a   Williams, Philip ^a   Chong, Anita ^b   Chari, Ravi ^a   Yin, Deng Ping ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

BLI; Cardiac transplantation; Mice; NF B; TLR

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; TOLL LIKE RECEPTOR 9;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CARDIAC GRAFT REJECTION; CELL TRANSFER; CONTROLLED STUDY; CPG ISLAND; ENZYME ACTIVITY; ENZYME INHIBITION; GRAFT SURVIVAL; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; REPERFUSION INJURY; SPLEEN CELL; TRANSGENIC MOUSE; TRANSPLANTATION TOLERANCE;

ADOPTIVE TRANSFER; ANIMALS; HEART TRANSPLANTATION; LUCIFERASES; LUMINESCENCE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; NF-KAPPA B; SPLEEN; TRANSPLANTATION, HOMOLOGOUS;

EID: 41149097203     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318166cde1     Document Type: Article

References (32)

1. Lee JI, Burckart GJ. Nuclear factor kappa B: Important transcription factor and therapeutic target. J Clin Pharmacol 1998; 38: 981.
2. Csizmadia V, Gao W, Hancock SA, et al. Differential NF-kappaB and IkappaB gene expression during development of cardiac allograft rejection versus CD154 monoclonal antibody-induced tolerance. Transplantation 2001; 71: 835.
3. Sadikot RT, Blackwell TS. Bioluminescence imaging. Proc Am Thorac Soc 2005; 2: 537.
4. Yull FE, Han W, Jansen ED, et al. Bioluminescent detection of endotoxin effects on HIV-1 LTR-driven transcription in vivo. J Histochem Cytochem 2003; 51: 741.
5. Roth DJ, Jansen ED, Powers AC, et al. A novel method of monitoring response to islet transplantation: Bioluminescent imaging of an NF-kB transgenic mouse model. Transplantation 2006; 81: 1185.
6. Chen X, Zhang X, Larson CS, et al. In vivo bioluminescence imaging of transplanted islets and early detection of graft rejection. Transplantation 2006; 81: 1421.
7. Chen L, Wang T, Zhou P, et al. TLR engagement prevents transplantation tolerance. Am J Transplant 2006; 6: 2282.
8. Tsung A, Hoffman RA, Izuishi K, et al. Hepatic ischemia/reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol 2005; 175: 7661.
9. Thornley TB, Brehm MA, Markees TG, et al. TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts. J Immunol 2006; 176: 1561.
10. Zhou P, Hwang KW, Palucki DA, et al. Impaired NF-kappaB activation in T cells permits tolerance to primary heart allografts and to secondary donor skin grafts. Am J Transplant 2003; 3: 139.
11. Ueki S, Yamashita K, Aoyagi T, et al. Control of allograft rejection by applying a novel nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin. Transplantation 2006; 82: 1720.
12. Kaibori M, Sakitani K, Oda M, et al. Immunosuppressant FK506 inhibits inducible nitric oxide synthase gene expression at a step of NF-kappaB activation in rat hepatocytes. J Hepatol 1999; 30: 1138.
13. Shen XD, Ke B, Zhai Y, et al. Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia/reperfusion injury. Am J Transplant 2005; 5: 1793.
14. Lentsch AB. Activation and function of hepatocyte NF-kappaB in postischemic liver injury. Hepatology 2005; 42: 216.
15. Frantz S, Tillmanns J, Kuhlencordt PJ, et al. Tissue-specific effects of the nuclear factor {kappa}B subunit p50 on myocardial ischemia-reperfusion injury. Am J Pathol 2007; 171: 507.
16. Blackwell JM, Searle S. Genetic regulation of macrophage activation: Understanding the function of Nramp1 (=Ity/Lsh/Bcg). Immunol Lett 1999; 65: 73.
17. Blackwell TS, Yull FE, Chen CL, et al. Multiorgan nuclear factor kappa B activation in a transgenic mouse model of systemic inflammation. Am J Respir Crit Care Med 2000; 162 (3 pt 1): 1095.
18. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973; 16: 343.
19. Yin D, Dujovny N, Ma L, et al. IFN-gamma production is specifically regulated by IL-10 in mice made tolerant with anti-CD40 ligand antibody and intact active bone. J Immunol 2003; 170: 853.
20. Yin D, Ma L, Zeng H, et al. Allograft tolerance induced by intact active bone co-transplantation and anti-CD40L monoclonal antibody therapy. Transplantation 2002; 74: 345.
21. Shen J, Chong AS, Xiao F, et al. Histological characterization and pharmacological control of chronic rejection in xenogeneic and allogeneic heart transplantation. Transplantation 1998; 66: 692.
22. Everhart MB, Han W, Sherrill TP, et al. Duration and intensity of NF-kappaB activity determine the severity of endotoxin-induced acute lung injury. J Immunol 2006; 176: 4995.
23. Tanaka M, Swijnenburg RJ, Gunawan F, et al. In vivo visualization of cardiac allograft rejection and trafficking passenger leukocytes using bioluminescence imaging. Circulation 2005; 112 (9 suppl): I105.
24. Takahashi Y, Ganster RW, Gambotto A, et al. Role of NF-kappaB on liver cold ischemia-reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2002; 283: G1175.
25. Larsen CP, Alexander DZ, Hollenbaugh D, et al. CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation 1996; 61: 4.
26. Niimi M, Pearson TC, Larsen CP, et al. The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo. J Immunol 1998; 161: 5331.
27. Cooper M, Lindholm P, Pieper G, et al. Myocardial nuclear factor-kappaB activity and nitric oxide production in rejecting cardiac allografts. Transplantation 1998; 66: 838.
28. Boyd JH, Mathur S, Wang Y, et al. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response. Cardiovasc Res 2006; 72: 384.
29. Andrade CF, Kaneda H, Der S, et al. Toll-like receptor and cytokine gene expression in the early phase of human lung transplantation. J Heart Lung Transplant 2006; 25: 1317.
30. Krieger NR, Yin DP, Fathman CG. CD4+ but not CD8+ cells are essential for allorejection. J Exp Med 1996; 184: 2013.
31. Phillips NE, Markees TG, Mordes JP, et al. Blockade of CD40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance. J Immunol 2003; 170: 3015.
32. Smiley ST, Csizmadia V, Gao W, et al. Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFkappaB: Implications for tolerance induction. Transplantation 2000; 70: 415.